CD274 and nasopharyngeal carcinoma: Increased expression of PD-L1 has been demonstrated in EBV-associated nasopharyngeal carcinoma28,29 and immune checkpoint inhibitors may potentially be useful as an adjuvant treatment in nasopharyngeal carcinoma when further radiotherapy is not possible or considered harmful30,31.